Jason Throne, SVP, General Counsel at IDEAYA Biosciences, Inc. (IDYA), sold 20,000 shares at $25.17 ($503K) on 2021-07-27, disclosed to the SEC on 2021-07-29.
Open-market sale of $503k IDYA by SVP, General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.17 | 10,000 | $252K | 50.0% |
| 2 | $25.17 | 10,000 | $252K | 50.0% |
| Total | $25.17 avg | 20,000 | $503K | 100% |
| Filing → |
| IDYA | SELL | 2023-09-14 | $30K | — | Filing → |
| IDYA | SELL | 2023-09-06 | $167K | — | Filing → |
| IDYA | SELL | 2023-08-11 | $125K | — | Filing → |